Key result
Vascular redox switches govern nitric oxide diffusion, offering novel therapeutic targets for hypertension.
Why the study?
To review the current understanding of redox switches controlling nitric oxide signaling in endothelial and vascular smooth muscle cells, their pathophysiological implications, and therapeutic advances for hypertension.
Answers are grounded in this paper and cite their sources.
This review summarizes the mechanisms by which redox switches control nitric oxide signaling in the resistance vasculature, with implications for blood pressure regulation and hypertension treatment.
The arterial resistance vasculature modulates blood pressure and flow to match oxygen delivery to tissue metabolic demand. As such, resistance arteries and arterioles have evolved a series of highly orchestrated cell-cell communication mechanisms between endothelial cells and vascular smooth muscle cells to regulate vascular tone. In response to neurohormonal agonists, release of several intracellular molecules, including nitric oxide, evokes changes in vascular tone. We and others have uncovered novel redox switches in the walls of resistance arteries that govern nitric oxide compartmentalization and diffusion. In this review, we discuss our current understanding of redox switches controlling nitric oxide signaling in endothelial and vascular smooth muscle cells, focusing on new mechanistic insights, physiological and pathophysiological implications, and advances in therapeutic strategies for hypertension and other diseases.
No takes yet. Share an insight, caveat, or question.
Dosunmu-Ogunbi et al. (2021) conducted a review in Hypertension. Redox switches in endothelial and vascular smooth muscle cells govern nitric oxide compartmentalization and diffusion, presenting novel therapeutic targets for the treatment of hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: